CN102440977A - 一种丁二磺酸腺苷酸肠溶组合物及制备方法 - Google Patents
一种丁二磺酸腺苷酸肠溶组合物及制备方法 Download PDFInfo
- Publication number
- CN102440977A CN102440977A CN2011102902092A CN201110290209A CN102440977A CN 102440977 A CN102440977 A CN 102440977A CN 2011102902092 A CN2011102902092 A CN 2011102902092A CN 201110290209 A CN201110290209 A CN 201110290209A CN 102440977 A CN102440977 A CN 102440977A
- Authority
- CN
- China
- Prior art keywords
- disulfonic acid
- acid
- compositions
- granule
- adenylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 title claims abstract description 29
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 title claims abstract description 29
- 229950006790 adenosine phosphate Drugs 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- FUDAIDRKVVTJFF-UHFFFAOYSA-N butane-1,1-disulfonic acid Chemical compound CCCC(S(O)(=O)=O)S(O)(=O)=O FUDAIDRKVVTJFF-UHFFFAOYSA-N 0.000 title abstract 6
- 239000002245 particle Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000001291 vacuum drying Methods 0.000 claims abstract description 10
- 239000008187 granular material Substances 0.000 claims description 49
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 26
- 238000005303 weighing Methods 0.000 claims description 19
- 235000019359 magnesium stearate Nutrition 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000741 silica gel Substances 0.000 claims description 16
- 229910002027 silica gel Inorganic materials 0.000 claims description 16
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 229920002521 macromolecule Polymers 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000004925 Acrylic resin Substances 0.000 claims description 5
- 229920000178 Acrylic resin Polymers 0.000 claims description 5
- 239000001856 Ethyl cellulose Substances 0.000 claims description 5
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 5
- 229920001249 ethyl cellulose Polymers 0.000 claims description 5
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 5
- 239000001923 methylcellulose Substances 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229960003943 hypromellose Drugs 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 235000010980 cellulose Nutrition 0.000 claims 2
- 239000002994 raw material Substances 0.000 abstract description 12
- 229920000642 polymer Polymers 0.000 abstract 2
- 206010008635 Cholestasis Diseases 0.000 abstract 1
- 230000007870 cholestasis Effects 0.000 abstract 1
- 231100000359 cholestasis Toxicity 0.000 abstract 1
- 238000005253 cladding Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 description 18
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 12
- 229960001570 ademetionine Drugs 0.000 description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 9
- 238000012856 packing Methods 0.000 description 9
- 229920003023 plastic Polymers 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000019890 Amylum Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 208000001024 intrahepatic cholestasis Diseases 0.000 description 2
- 230000007872 intrahepatic cholestasis Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- -1 0.001 Chemical compound 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001587 cholestatic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- HHCCNQLNWSZWDH-UHFFFAOYSA-N n-hydroxymethanimine oxide Chemical compound O[N+]([O-])=C HHCCNQLNWSZWDH-UHFFFAOYSA-N 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110290209.2A CN102440977B (zh) | 2011-09-18 | 2011-09-18 | 一种丁二磺酸腺苷酸肠溶组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110290209.2A CN102440977B (zh) | 2011-09-18 | 2011-09-18 | 一种丁二磺酸腺苷酸肠溶组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102440977A true CN102440977A (zh) | 2012-05-09 |
CN102440977B CN102440977B (zh) | 2014-05-28 |
Family
ID=46004239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110290209.2A Active CN102440977B (zh) | 2011-09-18 | 2011-09-18 | 一种丁二磺酸腺苷酸肠溶组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102440977B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114272220A (zh) * | 2021-12-22 | 2022-04-05 | 南京美瑞制药有限公司 | 一种丁二磺酸腺苷蛋氨酸肠溶片组合物及其制备方法 |
CN114306266A (zh) * | 2022-01-06 | 2022-04-12 | 济南同路医药科技发展有限公司 | 丁二磺酸腺苷蛋氨酸肠溶组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943787A (zh) * | 2006-10-24 | 2007-04-11 | 北京中医药大学 | 一种药物防潮组合物及其制备方法 |
CN101584684A (zh) * | 2009-06-04 | 2009-11-25 | 无锡鼎福药业有限公司 | 包括s-腺苷蛋氨酸稳定性盐的肠溶制剂及其制备方法 |
-
2011
- 2011-09-18 CN CN201110290209.2A patent/CN102440977B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1943787A (zh) * | 2006-10-24 | 2007-04-11 | 北京中医药大学 | 一种药物防潮组合物及其制备方法 |
CN101584684A (zh) * | 2009-06-04 | 2009-11-25 | 无锡鼎福药业有限公司 | 包括s-腺苷蛋氨酸稳定性盐的肠溶制剂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114272220A (zh) * | 2021-12-22 | 2022-04-05 | 南京美瑞制药有限公司 | 一种丁二磺酸腺苷蛋氨酸肠溶片组合物及其制备方法 |
CN114306266A (zh) * | 2022-01-06 | 2022-04-12 | 济南同路医药科技发展有限公司 | 丁二磺酸腺苷蛋氨酸肠溶组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102440977B (zh) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102766304A (zh) | 含三维石墨烯网络的高电导率聚合物复合材料及制备方法 | |
CN102440977B (zh) | 一种丁二磺酸腺苷酸肠溶组合物及制备方法 | |
CN103214604A (zh) | 一种用于悬浮聚合的无机-有机复合分散剂及其应用方法 | |
CN107951849B (zh) | 一种苯磺酸氨氯地平片及其制备方法 | |
CN102805740A (zh) | 重酒石酸卡巴拉汀胶囊及其制备方法 | |
CN105193753A (zh) | 一种阿奇霉素分散片的制备方法 | |
CN102309482B (zh) | 一种硫酸氢氯吡格雷组合物及其制备方法 | |
CN101829190B (zh) | 丹灯通脑片剂及其制备工艺 | |
CN103142525A (zh) | 奥氮平胃溶型片剂及其制备方法 | |
CN103933005A (zh) | 一种含有泮托拉唑钠的肠溶片及其制备方法 | |
CN103735544B (zh) | 一种维达列汀/盐酸二甲双胍复方制剂的制备工艺 | |
CN102772446A (zh) | 抗肿瘤药香菇多糖胶囊工业化生产工艺 | |
CN102266309A (zh) | 一种新型罗红霉素胶囊及其制备方法 | |
CN112190561B (zh) | 一种阿莫西林克拉维酸钾片剂的制备方法 | |
CN102000033B (zh) | 阿莫西林颗粒及其制备工艺 | |
CN104610582B (zh) | 一种全淀粉植物胶及其制备方法和应用 | |
CN102936179A (zh) | 一种硼-硅系延期药及其制造工艺 | |
CN106038523B (zh) | 一种枸橼酸钾枸橼酸钠片及其制备方法 | |
CN103142533B (zh) | 一种依托泊苷肠溶片 | |
CN104473882B (zh) | 一种甲钴胺颗粒 | |
CN102670531A (zh) | 一种洛索洛芬钠组合物 | |
CN112741808A (zh) | 一种提高含盐酸苄丝肼口服固体组合物稳定性的方法 | |
CN108992416A (zh) | 一种可利霉素肠溶片及其制备方法 | |
CN103284973A (zh) | 一种阿德福韦酯组合物及其制备方法 | |
CN108653330A (zh) | 一种阿胶颗粒剂及其生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180424 Address after: 100070 Beijing City, Fengtai District zaojiacheng Street South Lane No. 5 4A No. 2 layer Co-patentee after: JILIN DESHANG PHARMACEUTICAL CO.,LTD. Patentee after: BEIJING MANGE PHARMACEUTICAL S. & T. CO.,LTD. Address before: 100070 Beijing City, Fengtai District zaojiacheng Street South Lane No. 5 4A No. 2 layer Patentee before: BEIJING MANGE PHARMACEUTICAL S. & T. CO.,LTD. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to adenylate succinate enteric coated composition and a preparation method thereof Effective date of registration: 20210507 Granted publication date: 20140528 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: JILIN DESHANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2021220000046 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220810 Granted publication date: 20140528 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: JILIN DESHANG PHARMACEUTICAL CO.,LTD. Registration number: Y2021220000046 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of butanedisulfonic acid adenylate enteric-coated composition and preparation method thereof Effective date of registration: 20220811 Granted publication date: 20140528 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: JILIN DESHANG PHARMACEUTICAL CO.,LTD. Registration number: Y2022220000054 |